NovaSom introduces MediTrack OSA management platform

NewsGuard 100/100 Score

NovaSom, Inc., the leader in obstructive sleep apnea (OSA) home testing and cost-containment solutions, announces the launch of its next generation MediTrack® cloud-based CRM application. The MediTrack OSA management platform is designed to enable custom processing of payer-specific medical policy, billing, utilization management and therapy coordination requirements to efficiently manage home sleep testing, OSA diagnosis and recommended therapy.

NovaSom's proprietary MediTrack system allows physicians to order a NovaSom home sleep test online or by fax. The platform provides customizable information fields for easier physician entry of payer required data, leverages payer communication preferences, and incorporates payer-specific messaging into patient shipping and handling and device return logistics. The system also manages rapid upload of patient sleep data for interpretation by a Board Certified physician, and then promptly publishes the OSA study results for secure online and fax delivery to the ordering physician. Upon positive diagnosis, the MediTrack technology integrates assignment of payer-preferred therapy providers.

Richard Hassett, MD, CEO, NovaSom, Inc., said, "This significant technology investment allows NovaSom to provide a custom physician order workflow system that incorporates payer-specific medical policy, utilization management and therapy coordination. This end-to-end integration greatly reduces the administrative burden for physicians, payers and patients. The alignment with payer-designated therapy partners assures continuity between diagnosis and initiation of treatment."

Home sleep testing with NovaSom is a less expensive, convenient and clinically proven alternative to in-facility sleep testing, and appropriate for up to 80% of the undiagnosed OSA patient population. NovaSom is fully accredited by the Joint Commission as an Ambulatory Care Sleep Diagnostic Center and CMS approved as an Independent Diagnostic Testing Facility.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study unveils novel bladder cancer diagnostic model based on key mitochondrial genes